EPO and transient ischemic attack: We looked in particular at the role of hs-CRP as a biomarker of inflammation, PRDX1 as a marker of oxidative stress and EPO as a potential neuroprotective mediator in predicting further ischemic events in patients who had experienced a transient ischemic attack (TIA) or lacunar stroke.